Skip to content

Celiprolol

CARDIOVASCULAR SYSTEM

Also known as: celiprolol HCl, celiprolol hydrochloride, celiprolol monohydrochloride, DL-Celiprolol, selectol

YEAR INTRODUCED approvedATC C07AB08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Celiprolol is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1982. DrugCentral lists 3 molecular targets, including ADRB1, ADRB2 and Htr1a. Recorded indications include Angina pectoris and Hypertensive disorder.

  • Molecular targets: ADRB1, ADRB2 and Htr1a (3 listed in DrugCentral).
  • Indications: Angina pectoris and Hypertensive disorder.
  • ATC code: C07AB08 (Beta blocking agents, selective).
  • Molecular formula: C20H33N3O4; molecular weight 379.50 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Angina pectoris
  • Hypertensive disorder

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
Beta-1 adrenergic receptorADRB1antagonistKi 8.10
Beta-2 adrenergic receptorADRB2agonistKi 6.80
5-hydroxytryptamine receptor 1AHtr1aunknownKi 5.05

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1982-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
C07AB08CARDIOVASCULAR SYSTEM › BETA BLOCKING AGENTS › BETA BLOCKING AGENTS › Beta blocking agents, selective

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Nipple inflammation92.1
Bradycardia87.6
Acute kidney injury83.0
Nipple disorder67.0
Interstitial lung disease54.3
Prevertebral soft tissue swelling of cervical space49.6
Hyponatraemia49.3
Atrioventricular block complete47.2
Hepatocellular injury46.0
Eosinophilia45.9
Pemphigoid43.6
Hypotension38.1

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Celiprolol is on its molecule page.

Molecular formulaC20H33N3O4
Molecular weight379.50 g/mol
CAS number56980-93-9
InChIKeyJOATXPAWOHTVSZ-UHFFFAOYSA-N
PubChem CID2663
CCN(CC)C(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)(C)C)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Celiprolol used for?

DrugCentral lists the following indications for Celiprolol: Angina pectoris and Hypertensive disorder.

How does Celiprolol work?

Its molecular targets in DrugCentral include ADRB1 (antagonist), ADRB2 (agonist) and Htr1a.

When was Celiprolol first approved?

Celiprolol was first approved by the YEAR INTRODUCED in 1982.

What is the chemical formula of Celiprolol?

Celiprolol has the molecular formula C20H33N3O4 and a molecular weight of 379.50 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1982-01-01
AgencyYEAR INTRODUCED
Targets3
Indications2
FormulaC20H33N3O4
DrugCentral ID569
Interactive profile